Cargando…
Drugs of abuse and the adolescent athlete
Doping with endocrine drugs is quite prevalent in amateur and professional athletes. The World Anti-Doping Agency (WADA) has a list of banned drugs for athletes who compete and a strategy to detect such drugs. Some are relatively easy, anabolic steroids and erythropoietin, and others more difficult,...
Autor principal: | |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2830221/ https://www.ncbi.nlm.nih.gov/pubmed/20167068 http://dx.doi.org/10.1186/1824-7288-36-19 |
_version_ | 1782178153084485632 |
---|---|
author | Rogol, Alan D |
author_facet | Rogol, Alan D |
author_sort | Rogol, Alan D |
collection | PubMed |
description | Doping with endocrine drugs is quite prevalent in amateur and professional athletes. The World Anti-Doping Agency (WADA) has a list of banned drugs for athletes who compete and a strategy to detect such drugs. Some are relatively easy, anabolic steroids and erythropoietin, and others more difficult, human growth hormone (rhGH) and insulin like growth factor I (IGF-I). The use of such compounds is likely less in adolescent athletes, but the detection that much more difficult given that the baseline secretion of the endogenous hormone is shifting during pubertal development with the greatest rise in testosterone in boys occuring about the time of peak height velocity and maximal secretion of hGH and IGF-I. This review notes the rationale, physiology, performance enhancement, adverse events and the detection of doping with insulin, rhGH, rhIGF-I, erythropoietin, and anabolic-androgenic steroids. |
format | Text |
id | pubmed-2830221 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-28302212010-03-02 Drugs of abuse and the adolescent athlete Rogol, Alan D Ital J Pediatr Review Doping with endocrine drugs is quite prevalent in amateur and professional athletes. The World Anti-Doping Agency (WADA) has a list of banned drugs for athletes who compete and a strategy to detect such drugs. Some are relatively easy, anabolic steroids and erythropoietin, and others more difficult, human growth hormone (rhGH) and insulin like growth factor I (IGF-I). The use of such compounds is likely less in adolescent athletes, but the detection that much more difficult given that the baseline secretion of the endogenous hormone is shifting during pubertal development with the greatest rise in testosterone in boys occuring about the time of peak height velocity and maximal secretion of hGH and IGF-I. This review notes the rationale, physiology, performance enhancement, adverse events and the detection of doping with insulin, rhGH, rhIGF-I, erythropoietin, and anabolic-androgenic steroids. BioMed Central 2010-02-18 /pmc/articles/PMC2830221/ /pubmed/20167068 http://dx.doi.org/10.1186/1824-7288-36-19 Text en Copyright ©2010 Rogol; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Rogol, Alan D Drugs of abuse and the adolescent athlete |
title | Drugs of abuse and the adolescent athlete |
title_full | Drugs of abuse and the adolescent athlete |
title_fullStr | Drugs of abuse and the adolescent athlete |
title_full_unstemmed | Drugs of abuse and the adolescent athlete |
title_short | Drugs of abuse and the adolescent athlete |
title_sort | drugs of abuse and the adolescent athlete |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2830221/ https://www.ncbi.nlm.nih.gov/pubmed/20167068 http://dx.doi.org/10.1186/1824-7288-36-19 |
work_keys_str_mv | AT rogolaland drugsofabuseandtheadolescentathlete |